The beautiful work from Hui’s thesis is out. The power of collaboration in Science (literally!). science.org/doi/10.1126/sc…

Wow 🌟

1/ Results from #LITESPARK-005 are out NEJM! The phase 3 trial that led to HIF-2 inhibitor Belzutifan (BEL) U.S. FDA approval Dec 2023 in pretreated pts w/ #ccRCC. Presentation #ESMO24 @myEsmo Check it out: nejm.org/doi/full/10.10…

I had the opportunity to represent #ClinicObiome Gustave Roussy as a partner of the #HumanMicrobiomeAction EU Project. Beyond innovative translational projects, we advocate for the acknowledgement of consensus and requirements in the microbiome field. 🔎 thelancet.com/journals/lanmi…

La maison des parcours inaugurée vendredi par Anne BRUANT-BISSON @ARS_Martinique Le Brière Jérôme CHU de Martinique avec les élus et les asso, va héberger le dispositif Oncorapido pour optimiser l’entrée dans le parcours de soin du cancer en Martinique 👏🏾👏🏾👏🏾#UCOM Fédération Amazones La Ligue contre le cancer

Excited to present our study on #ExerciseOncology for pts w #LungCancer at #WCLC24 IASLC Cristiane D Bergerot dr.paulo.lages.oncologia William Fuzita Enrique Soto Dr Kathryn Schmitz Narjust Florez, MD, FASCO

So proud of Cristiane D Bergerot - after a stellar talk at #WCLC24, she is headed to #ESMO24 to educate us once again. Hard to find someone who works harder to advance #supportivecare. Neeraj Agarwal, MD, FASCO Petros Grivas Toni Choueiri, MD Shilpa Gupta Shuchi Gulati MD Matthew Loscalzo, LCSW City of Hope

Pit stop at beautiful Porto just before #ESMO2024 to attend #EHMSG2024 and present highlights on microbiota-modulated immune check point research from #ClinicOBiome Gustave Roussy at #EHMSG workshop.

Exciting ESMO24 for microbiome! Come check out our poster reporting the clinical results from our FMT-LUMINate trial in NSCLC and melanoma Thank you ESMO - Eur. Oncology for the Merit Award

TiNivo-2 answers a crucial question: is ICI-rechallenge the right thing to do in mRCC? The data says NO Great presentation by Toni Choueiri, MD with concomitant publication in The Lancet Oncology #ESMO2024

Excited about Cristiane D Bergerot's talk at the #ESMO24 Educational Session on addressing sexual health in female and male cancer patients! Matteo Lambertini, MD PhD ESMO - Eur. Oncology Isabelle Demeestere Christine Wyns

Kudos to @alicefranzoi for an excellent job discussing the data on breastfeeding after breast cancer, presented at the ESMO - Eur. Oncology Preferred Paper Session on Supportive Care session moderated by Matteo Lambertini, MD PhD OncoAlert

Wanted to give a quick shoutout to my two former City of Hope research fellows Cristiane D Bergerot & @paulobergerot. We starting working together more than a decade ago. Now, Paulo is developing programs to formally assess #exercise in #oncology within #Brazil. Cris leads

Excellent discussion of pitfalls and practical implications of the PEACE 3 data by Prof Karim Fizazi. 1. Clinical benefit clear PFS/OS 2. Fracture prevention 3. BP monitoring 4. Only for ARPI naive pts 5. More data to come! #ESMO2024

New 1L SoC in metastatic #analcancer : Retifanlimab + CarboTax vs CarboTax: ✅ PFS: 9.3 vs 7.4 mo ✅ OS trend: 23 vs 29 mo ✅ ORR: 48% vs 36% Congrats Sheela Rao et al👏👏 Just missed participation of countries where #analcancer is frequent (Brazil, South Africa )

Not all patients have resistance related to gut dysbiosis and patient selection is the key. The huge work of #ClinicObiome Gustave Roussy and collaborators on the field. 📖 our review on current gut microbiota-related biomarkers. annualreviews.org/content/journa…

Work from the IMDC database looking at surrogate markers of survival in kidney cancer #ESMO2024 . Work led by super star MD-scientist Renee Maria Saliby who is now a Yale Internal Medicine program! Dana-Farber Dana-Farber News ESMO - Eur. Oncology Mark D. Siegel

Great work by my dear Dana-Farber Lank Center for Genitourinary Oncology colleague Marc Machaalani who explored ERBB2 amplifications across different cancer types in the AACR projectGENIE presented at ESMO - Eur. Oncology !

🏆 Un grand bravo à Dr Antonio di Meglio, Dr Cédric Pobel, Dr Adèle Bonato, Dr Adrien Rousseau, Dr Arianna Marinello pour le prix du "Merit Travel Grant" de l'#ESMO24.

#ESMO2024 what an honor to be part of #neuroendocrinetumors educational session w amazing experts Garcia-Carbonero's Lab Simona Glasberg